Floatz logo

Therapeutic Asset Ratings

622 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Oki-219
Breast Cancer
OnKure, Inc.P1C (36)
pf-07224826
Breast Cancer
PfizerP1C (36)
P-Muc1C-Allo1 Car-T Cells
Breast Cancer
Poseida Therapeutics, Inc.P1C (36)
Pvx-410
Breast Cancer
Massachusetts General HospitalP1C (36)
QXL138AM
Breast Cancer
Nammi Therapeutics IncP1C (36)
Recombinant Humanized Type Iii Collagen
Breast Cancer
Peking University People's HospitalP1C (36)
Rgt-419B
Breast Cancer
Regor Pharmaceuticals Inc.P1C (36)
Rgt-490
Breast Cancer
Regor Pharmaceuticals Inc.P1C (36)
Rimiducid
Breast Cancer
M.D. Anderson Cancer CenterP1C (36)
SAR443216
Breast Cancer
SanofiP1C (36)
Son-Dp
Breast Cancer
Qurgen Inc.P1C (36)
syn608
Breast Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdP1C (36)
syn818
Breast Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdP1C (36)
sys6043
Breast Cancer
Conjupro Biotherapeutics, Inc.P1C (36)
tas2940
Breast Cancer
Taiho Oncology, Inc.P1C (36)
Tazemetostat
Breast Cancer
Dana-Farber Cancer InstituteP1C (36)
Tbio-4101
Breast Cancer
Turnstone Biologics, Corp.P1C (36)
Valemetostat
Breast Cancer
M.D. Anderson Cancer CenterP1C (36)
Vsv-02
Breast Cancer
The First Affiliated Hospital of Xinxiang Medical CollegeP1C (36)
99mTc-ABH2
Breast Cancer
Peking Union Medical College HospitalEarly P1C (36)
Pacritinib
Breast Cancer
National University Hospital, SingaporeP1/2C (36)
egf816
Breast Cancer
M.D. Anderson Cancer CenterP1/2C (35)
Benralizumab
Breast Cancer
Memorial Sloan Kettering Cancer CenterP2C (33)
Tas-109
Breast Cancer
Dana-Farber Cancer InstituteP1C (33)
[177Lu]Lu-HT547
Breast Cancer
Hua PangEarly P1C (33)
Showing 526 to 550 of 622 assets
PreviousPage 22 of 25Next